Objective:
To explore the future advancements and potential of orthokeratology (ortho-k) in myopia control and other refractive needs.
Approach:
- Ortho-k effectively slows myopia progression and is preferred for children needing daytime freedom from correction.
- Combination therapy with low-dose atropine shows enhanced efficacy for myopia control.
- Patient selection and motivation are critical for successful ortho-k outcomes.
- AI-assisted fitting can improve clinical efficiency and reduce variability in treatment success.
- No treatment combination has shown 100% efficacy in myopia control.
- Limited commercial availability of hyperopic and presbyopic ortho-k lenses.
- Patient expectations must be managed to avoid frustration.
- Lipson et al, 2018
- Xu et al, 2023
- Tang et al, 2024
- Sánchez-González et al, 2020
- Sankaridurg et al, 2025
- Lan et al, 2024
Key Findings:
Interpretation:
The advancements in ortho-k suggest a promising future for personalized refractive care, particularly in managing myopia and accommodating other refractive errors.
Limitations:
Conclusion:
Ortho-k is set to evolve with technological advancements, offering improved treatment outcomes for a wider range of refractive needs.
Sources:
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.